ADJUTEC PHARMA AS
Signals
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−1,5 mill kr).
ADJUTEC PHARMA AS is registered as a limited company in Oslo, Oslo with organisation number 923831762. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2019. Registered share capital is NOK 58,000, divided into 57750 shares. The company's stated purpose is: “Forskning, utvikling, markedsføring og salg av nye hjelpestoffer (adjuvanter) som motvirker antibiotikaresistens, slik at kjente antibiotika virker bedre.”.
Key figures · 2025
Financial health · 2025
Who owns ADJUTEC PHARMA AS?
ADJUTEC PHARMA AS has 20+ registered shareholders:
- PATIAS INNOVATION AS 49.2%
- KISTEFOS AS 9.4%
- INVEN2 AS 5.4%
- HELENE SUNDT AS 4.9%
- WEIERGANGART AS 3.2%
- TRYLLEBO AS 3.2%
- HØSE AS 3.1%
- CGS HOLDING AS 2.4%
- LEMUREN AS 2.3%
- WEIER AS 2.1%
- RADFORSK INVESTERINGSSTIFTELSE 1.7%
- SUNDT AS 1.5%
- FARVATN VENTURE AS 1.5%
- ADJUTEC PHARMA AS 1.4%
- JANDERSEN KAPITAL AS 1.4%
- MYRLID AS 1.4%
- WIBO CONSULTING AS 1.1%
- KEN HOLDING AS 1.1%
- STAR KAPITAL AS 1.0%
- OSLO CANCER CLUSTER INCUBATOR AS 0.7%
Which companies does ADJUTEC PHARMA AS own?
ADJUTEC PHARMA AS holds a stake in 1 company:
- ADJUTEC PHARMA AS 1.4%
Frequently asked questions about ADJUTEC PHARMA AS
Who owns ADJUTEC PHARMA AS?
PATIAS INNOVATION AS is the largest registered owner, with 49.2%.
Who is the general manager of ADJUTEC PHARMA AS?
Jethro Lee Holter is registered as general manager of ADJUTEC PHARMA AS.
Where is ADJUTEC PHARMA AS based?
ADJUTEC PHARMA AS has its business address in Oslo.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 02.09.2026.